Optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas
Aim. To identify the optimal combination of cardiovascular toxicity (CVT) markers for subsequent optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas.Material and methods. This prospective study was conducted to monitor cardiovascular adverse events i...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
«SILICEA-POLIGRAF» LLC
2026-04-01
|
| Серія: | Кардиоваскулярная терапия и профилактика |
| Предмети: | |
| Онлайн доступ: | https://cardiovascular.elpub.ru/jour/article/view/4514 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|